CSPC Pharmaceutical Group (1093N) Income Statement

0 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q2 2026), CSPC Pharmaceutical Group's total revenue was HK$18.34B, an increase of 11.72% from the same quarter last year. In Q2, CSPC Pharmaceutical Group's net income was HK$6.01B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 25.33B	¥ 29.54B	¥ 31.47B	¥ 31.59B	¥ 27.41B
Gross Profit	¥ 16.62B	¥ 20.67B	¥ 22.19B	¥ 22.73B	¥ 20.79B
Operating Expenses	¥ 12.75B	¥ 15.22B	¥ 15.19B	¥ 15.80B	¥ 14.64B
Depreciation and Amortization	¥ 1.37B	¥ 1.36B	¥ 1.11B	¥ 1.07B	¥ 849.47M
EBITDA	¥ 5.24B	¥ 7.18B	¥ 8.59B	¥ 8.85B	¥ 7.57B
Operating Income	¥ 3.87B	¥ 5.45B	¥ 7.01B	¥ 6.93B	¥ 6.14B
Other Income/Expenses	¥ 815.45M	¥ 229.71M	¥ 388.72M	¥ 811.55M	¥ 591.96M
Pretax Income	¥ 4.68B	¥ 5.68B	¥ 7.39B	¥ 7.74B	¥ 6.73B
Net Income	¥ 3.78B	¥ 4.41B	¥ 5.88B	¥ 6.22B	¥ 5.51B
Per Share Metrics
Basic EPS	¥ 0.33	¥ 0.38	¥ 0.50	¥ 0.52	¥ 0.46
Diluted EPS	¥ 0.33	¥ 0.38	¥ 0.49	¥ 0.52	¥ 0.46
Weighted Average Shares Outstanding	11.42B	11.74B	11.87B	11.92B	11.95B
Weighted Average Shares Outstanding (Diluted)	11.42B	11.74B	11.87B	11.92B	11.95B

CSPC Pharmaceutical Group (1093N) Income Statement

CSPC Pharmaceutical Group Income Statement

CSPC Pharmaceutical Group Earnings and Revenue History